François Bertucci

发表

Linking Interactome to Disease: A Network-Based Analysis of Metastatic Relapse in Breast Cancer

Ghislain Bidaut, Daniel Birnbaum, Maxime Garcia, 2011, Handbook of Research on Computational and Systems Biology.

Interactome-transcriptome integration for predicting distant metastasis in breast cancer

Ghislain Bidaut, Daniel Birnbaum, Maxime Garcia, 2012, Bioinform..

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Wei Huang, Leming Shi, Yi Xiao, 2019, Clinical Cancer Research.

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer

Daniel Birnbaum, Marc Lopez, Terje Johansen, 2016, Nature Communications.

Basal and luminal breast cancers: basic or luminous? (review).

Daniel Birnbaum, François Bertucci, F. Bertucci, 2004, International journal of oncology.

Expression scanning of an array of growth control genes in human tumor cell lines

Samuel Granjeaud, Daniel Birnbaum, Béatrice Loriod, 1999, Oncogene.

8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer

Daniel Birnbaum, Anthony Ferrari, Sylviane Olschwang, 2012, PloS one.

Identification and validation of an ERBB2 gene expression signature in breast cancers

Daniel Birnbaum, Pascal Finetti, François Bertucci, 2004, Oncogene.

How different are luminal A and basal breast cancers?

Daniel Birnbaum, Dominique Maraninchi, Pascal Finetti, 2009, International journal of cancer.

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.

François Bertucci, Mario Campone, F. Bertucci, 2017, European journal of cancer.

Reasons for breast cancer heterogeneity

Daniel Birnbaum, François Bertucci, F. Bertucci, 2008, Journal of biology.

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

Daniel Birnbaum, Pascal Finetti, François Bertucci, 2014, Molecular Cancer.

Genomic characterization of metastatic breast cancers

Yahia Adnani, Thomas Bachelot, Florence Dalenc, 2019, Nature.

A gene expression signature identifies two prognostic subgroups of basal breast cancer

Daniel Birnbaum, Christian Chabannon, Pascal Finetti, 2011, Breast Cancer Research and Treatment.

H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b

Sylvain Julien, Pascal Finetti, François Bertucci, 2015, Oncotarget.

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

Daniel Birnbaum, Dominique Maraninchi, François Bertucci, 2005, Cancer research.

High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes

Daniel Birnbaum, Anthony Ferrari, Pascal Finetti, 2011, PloS one.

Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers

Daniel Birnbaum, Pascal Finetti, François Bertucci, 2006, Clinical Cancer Research.

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis

Daniel Birnbaum, Jean-Paul Borg, Pascal Finetti, 2011, Breast Cancer Research and Treatment.

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

Daniel Birnbaum, Dominique Maraninchi, Pascal Finetti, 2006, Cancer research.

Genomic profiling of inflammatory breast cancer: a review.

Daniel Birnbaum, Pascal Finetti, François Bertucci, 2014, Breast.

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

Lydie Lane, Daniel Birnbaum, Jean-Paul Borg, 2011, PloS one.

How basal are triple‐negative breast cancers?

Daniel Birnbaum, Pascal Finetti, François Bertucci, 2008, International journal of cancer.

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Daniel Birnbaum, Rémi Houlgatte, Pascal Finetti, 2005, Cancer research.

Re: Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Daniel Birnbaum, François Bertucci, F. Bertucci, 2002, Journal of the National Cancer Institute.

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy.

Daniel Birnbaum, Jiyang Yu, Carlos Cordon-Cardo, 2017, Genes & development.

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin

Daniel Birnbaum, Karima Mrad, François Bertucci, 2008, BMC Cancer.

Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling

Salvatore Spicuglia, Daniel Birnbaum, Stéphane Raynaud, 2014, PloS one.

Genome profiling of ERBB2-amplified breast cancers

Daniel Birnbaum, Charlène Innocenti, Fabrice Sircoulomb, 2010, BMC Cancer.

Integrated profiling of basal and luminal breast cancers.

Daniel Birnbaum, Fabrice Sircoulomb, Pascal Finetti, 2007, Cancer research.

Genomic and expression analysis of microdissected inflammatory breast cancer

Randa El-Zein, Massimo Cristofanilli, Savitri Krishnamurthy, 2013, Breast Cancer Research and Treatment.

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls”

Dominique Maraninchi, François Bertucci, F. Bertucci, 2019, Cancers.

Gene expression profiling and prediction of clinical outcome in ovarian cancer.

Daniel Birnbaum, Pascal Finetti, François Bertucci, 2009, Critical reviews in oncology/hematology.

DNA Arrays in Clinical Oncology: Promises and Challenges

Daniel Birnbaum, Rémi Houlgatte, François Bertucci, 2003, Laboratory Investigation.

The Functional Landscape of Hsp27 Reveals New Cellular Processes such as DNA Repair and Alternative Splicing and Proposes Novel Anticancer Targets*

Anaïs Baudot, Daniel Birnbaum, Christine Brun, 2014, Molecular & Cellular Proteomics.

Breast cancer revisited using DNA array‐based gene expression profiling

Daniel Birnbaum, Pascal Hingamp, Rémi Houlgatte, 2003, International journal of cancer.